Diethyl Ether → (2R)-2-Amino-4-(7-hydroxy-2-oxo-2H-1-benzopyran-4-yl)butanoic acid
反応式
C([O:3][C:4](=O)[CH2:5][C:6](=O)[CH2:7][CH2:8][C@H:9]([NH:20]C(OCC1C=CC=CC=1)=O)[C:10]([O:12]CC1C=CC=CC=1)=[O:11])C.[C:33]1([CH:40]=[CH:39][CH:38]=[C:36]([OH:37])[CH:35]=1)[OH:34].CCOCC.C(O)(C(F)(F)F)=O>CS(O)(=O)=O.O.CC#N>[CH:40]1[C:33]([OH:34])=[CH:35][C:36]2[O:37][C:4]([CH:5]=[C:6]([CH2:7][CH2:8][C@@H:9]([NH2:20])[C:10]([OH:12])=[O:11])[C:38]=2[CH:39]=1)=[O:3]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
(2S)-2 Benzyloxycarbonylamino-5-oxo-heptanedioic acid 1-benzyl ester 7-ethyl ester from the previous step (2.35 g, 5 mmol) was added slowly to resorcinol (3 g, 25 mmol) in methanesulfonic acid (20 ml) and stirred for two hours at room temperature. Five volumes of ether were then added to the mixture and was cooled to −30° C. The precipitate was washed with cold ether, dissolved in water, filtered, and lyophilized. L-(7-hydroxycoumarin-4-yl)ethylglycine was purified by reverse phase HPLC to afford a brown solid in 50% yield (YMC AA12S052503WT column, 12 ml/min flow rate, from 10% to 90% CH3CN, 0.1% TFA (w/v) in water, over the course of 12 min). 1H-NMR (DMSO): δ 2.06 (s, 2H), 2.70-2.90 (m, 2H), 3.82-4.0 (m, 1H), 6.06 (s, 1H), 6.75 (dd, J=8.8, 2.4, 1H), 6.82 (d, J=2.4, 1H), 7.62 (d, J=8.8, 1H), 8.17 (s, 3H). LC-MS (ESI) calc. for C13H14NO5 (M+H+) 264.08 Da, obsd. 264.0 Da.
後処理
- temperaturewas cooled to −30° C
- washThe precipitate was washed with cold ether
- dissolutiondissolved in water
- filtrationfiltered
- customL-(7-hydroxycoumarin-4-yl)ethylglycine was purified by reverse phase HPLC
- customto afford a brown solid in 50% yield (YMC AA12S052503WT column, 12 ml/min flow rate
- customover the course of 12 min
出典と根拠
- ORDレコード
- ord-284888904ee542a7a965ddd2261c7e47
- 出典データセット
- uspto-grants-2012_06
- 特許番号
- US08192952B2
反応ノート
読み込み中…